Bio21 Molecular Science & Biotechnology Institute

Academia and industry join forces against malaria

Professor Leann Tilley and Dr Stanley Xie from the Bio21 Institute are working with experts from the Japanese company, Takeda Pharmaceuticals, and Swiss-based foundation, Medicines for Malaria Venture (MMV), in a double-pronged effort to develop new antimalarial drugs.
$14m invested to create vaccine for debilitating periodontal gum disease

Melbourne Dental School Head of School Mike Morgan, CSL Senior Vice President of Research Andrew Nash, University of Melbourne Vice-President (Enterprise) Doron Ben-Meir, COHR CEO & Director of Research Eric Reynolds, Member for Higgins Katie Allen and Brandon Capital Investment Manager Ingmar Wahlqvist at the launch of Denteric.
Georgina Sweet Awards for Women in Quantitative Biomedical Science - 2 - 5pm, Monday, 14 October 2019

Join us to celebrate the winners of the 4th Round of Georgina Sweet Awards for Women in Quantitative Biomedical Science
Women of Bio21 - Justine Mintern

Read about Justine Mintern, Biochemistry and Molecular Biology, Head of Vaccine Biology Lab
New Microscope installed in Department of Biochemistry @Bio21

An exciting new microscope has been installed in the Biochemistry and Molecular Biology Node of the Biological Optical Microscopy Platform at the Bio21 Institute, 28 August 2019.

Search form

Home